Title

Gut Bacterial Tyrosine Decarboxylases Restrict Levels Of Levodopa In The Treatment Of Parkinson’s Disease

Creator

Bailey D'Antonio, University of New EnglandFollow
Laura Yamagata, University of New EnglandFollow

Faculty Advisor(s)

Dana L. Villmore

Files

Description

Research review poster of article:
van Kessel, S.P., Frye, A.K., El-Gendy, A.O. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease. Nat Commun 10, 310 (2019) doi:10.1038/s41467-019-08294-y

UNE Physician Assistant students reviewed research whose purpose was to analyze the effect of levodopa-metabolizing bacteria at its primary site of absorption, the jejunum, and further use this information to understand the variability in L-DOPA dosage requirements for individual treatment of Parkinson’s Disease.

Publication Date

12-2019

Disciplines

Medicine and Health Sciences

Related Materials

Original research article:
van Kessel, S.P., Frye, A.K., El-Gendy, A.O. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease. Nat Commun 10, 310 (2019) doi:10.1038/s41467-019-08294-y

Preferred Citation

D'Antonio, Bailey and Yamagata, Laura, "Gut Bacterial Tyrosine Decarboxylases Restrict Levels Of Levodopa In The Treatment Of Parkinson’s Disease" (2019). Physician Assistant Student Research Posters. 2.
https://dune.une.edu/pa_studpost/2